Back

Ezetimibe/Atorvastatin  Tablets

10/10, 10/20, 10/40 & 10/80 mg

Cardiovascular

details

Ezetimibe/Atorvastatin 10mg/10mg is indicated for the prevention of Cardiovascular Events:

  • To reduce the risk of cardiovascular events in patients with coronary heart disease (CHD) and a history of acute coronary syndrome (ACS), either previously treated with a statin or not.
  • As adjunctive therapy to diet for use in adults with primary (heterozygous familial and non-familial) hypercholesterolaemia or mixed hyperlipidaemia where use of a combination product is appropriate:
    • patients not appropriately controlled with a statin alone
    • patients already treated with a statin and ezetimibe
    • Homozygous Familial Hypercholesterolaemia (HoFH)
  • As adjunctive therapy to diet for use in adults with Homozygous Familial Hypercholesterolaemia (HoFH). Patients may also receive adjunctive treatments (e.g., low-density lipoprotein [LDL] apheresis)
  • ATC4: C10BA
  • Strengths: 10/10, 10/20, 10/40 & 10/80 mg
  • Dosage Form: Tablets
  • Dossier in CTD format is available for submission

Out-licensing: offered for all international market

* Product availability is subject to patent restrictions in countries where applicable patents are in effect

related products